Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Asia Diagnostics Summit 2018


Regulatory Challenges on Commercialization of Emerging Precision Medicine Technology-based Product

Ting-Shou Chen, Division Director, Industrial Technology Research Institute

After the announcement of precision medicine initiative in 2015, precision medicine has become an emerging research area, and in these years, a lot of companies aiming at this burgeoning around the world. Among these, some of them focus on diagnostic service or novel biomarker, but as the regulatory authority begins to eye on so called “LDT (Laboratory Developed Test)”, there will be some impacts on this emerging industry. This session explores some recent examples related to the strategies and implementation of precision medicine and the possible impact of regulation.

Add to Calendar ▼2018-11-05 00:00:002018-11-06 00:00:00Europe/LondonAsia Diagnostics Summit 2018Asia Diagnostics Summit 2018 in Taipei, TaiwanTaipei,